Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TScan Therapeutics, Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 1.12M | Jun 13, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TCRX | TScan Therapeutics, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Chief Executive Officer, Director |
TCRX | TScan Therapeutics, Inc. | Feb 2, 2023 | 1 | $0 | 4 | Feb 6, 2023 | Chief Scientific and Operations Officer |
TCRX | TScan Therapeutics, Inc. | Jul 25, 2022 | 1 | $0 | 4 | Jul 27, 2022 | Chief Scientific and Operations Officer |
TCRX | TScan Therapeutics, Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 20, 2022 | Chief Scientific Officer |
TCRX | TScan Therapeutics, Inc. | Sep 20, 2021 | 2 | $31.1K | 4 | Sep 22, 2021 | Chief Scientific Officer |
TCRX | TScan Therapeutics, Inc. | Jul 15, 2021 | 0 | $0 | 3 | Jul 15, 2021 | Chief Scientific Officer |